William Kevin Kelly, DO
Senior Investigator, Drug Development, Sarah Cannon Research Institute at Sidney Kimmel Cancer Center
Dr. Kelly joined Sarah Cannon Research Institute at Sidney Kimmel Cancer Center in 2018 when the two organizations announced a collaboration to advance clinical research through an expanded early phase drug development program. He serves as senior investigator of drug development, associate director of clinical research at the Sidney Kimmel Cancer Center and director of solid tumor oncology in department of oncology at Thomas Jefferson University.
Kelly received a Bachelor of Arts in mathematics from Emory University and a Doctor of Osteopathic Medicine from Philadelphia College of Osteopathic Medicine. He then completed his internal medicine residency at Albert Einstein Medical Center followed by his fellowship in medical oncology at Memorial Hospital for Cancer and Allied Diseases, and Joan and Sanford Weill Medical College of Cornell University. Prior to joining Thomas Jefferson University, Kelly was on faculty at Memorial Sloan Kettering Cancer Center\Joan and Sanford Weill Medical College of Cornell University and Yale School of Medicine. He is board certified in medical oncology.